Suppr超能文献

肾移植术后脓毒症:临床、免疫学及微生物学危险因素

Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.

作者信息

Schachtner Thomas, Stein Maik, Reinke Petra

机构信息

Department of Nephrology and Internal Intensive Care, Charité University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany.

Berlin-Brandenburg Center of Regenerative Therapies (BCRT), Berlin, Germany.

出版信息

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12695. Epub 2017 May 9.

Abstract

BACKGROUND

As immunosuppressive therapy and allograft survival have improved, the increased incidence of sepsis has become a major hurdle of disease-free survival after renal transplantation.

METHODS

We identified 112 of 957 kidney transplant recipients (KTRs) with sepsis. In all, 31 KTRs developed severe sepsis or septic shock, and 30 KTRs died from sepsis. KTRs without sepsis were used for comparison. CMV-specific and alloreactive T cells were measured using an interferon-γ Elispot assay. The extent of immunosuppression was quantified by lymphocyte subpopulations.

RESULTS

Five-year patient survival was 70.3% with sepsis compared to 88.2% without (P<.001). Five-year estimated glomerular filtration rate was lower in KTRs developing sepsis (P<.001). Upon multivariate analysis, diabetes, lymphocyte-depleting induction, donor age, CMV replication, and acute rejection increased the risk of sepsis (P<.05). Age, diabetes, underweight/obesity, and pneumonia as site of infection were predictive factors of mortality (P<.05). Early-onset sepsis was associated with decreased CD3+ and CD4+ T cells pre-transplantation (P<.05). Impaired CMV-specific cellular immunity pre-transplantation was associated with CMV replication and early-onset sepsis (P<.05). High frequencies of alloreactive T cells were associated with acute rejection, lymphocyte-depleting rejection treatment, and early-onset sepsis (P<.05).

CONCLUSION

KTRs developing sepsis show inferior patient survival and allograft function. Identified risk factors and differences in lymphocyte counts, CMV-specific immunity, and alloreactivity may prove useful to identify KTRs at increased risk.

摘要

背景

随着免疫抑制治疗的改进和同种异体移植存活率的提高,脓毒症发病率的增加已成为肾移植后无病生存的主要障碍。

方法

我们在957例肾移植受者(KTR)中确定了112例发生脓毒症的患者。总共有31例KTR发生了严重脓毒症或脓毒性休克,30例KTR死于脓毒症。将未发生脓毒症的KTR用作对照。使用干扰素-γ酶联免疫斑点试验测量巨细胞病毒(CMV)特异性和同种异体反应性T细胞。通过淋巴细胞亚群对免疫抑制程度进行量化。

结果

发生脓毒症的患者5年生存率为70.3%,未发生脓毒症的患者为88.2%(P<0.001)。发生脓毒症的KTR的5年估计肾小球滤过率较低(P<0.001)。多因素分析显示,糖尿病、淋巴细胞清除诱导、供体年龄、CMV复制和急性排斥反应增加了脓毒症的风险(P<0.05)。年龄、糖尿病、体重过轻/肥胖以及感染部位为肺炎是死亡率的预测因素(P<0.05)。早期脓毒症与移植前CD3+和CD4+T细胞减少有关(P<0.05)。移植前CMV特异性细胞免疫受损与CMV复制和早期脓毒症有关(P<0.05)。同种异体反应性T细胞的高频率与急性排斥反应、淋巴细胞清除性排斥反应治疗和早期脓毒症有关(P<0.05)。

结论

发生脓毒症的KTR患者生存率和同种异体移植功能较差。已确定的风险因素以及淋巴细胞计数、CMV特异性免疫和同种异体反应性的差异可能有助于识别脓毒症风险增加的KTR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验